Keyphrases
Pancreatic Ductal Adenocarcinoma
100%
Licochalcone A
100%
EEF2
100%
Pyroptosis
100%
Pancreatic Duct Cells
27%
Dual Function
9%
Cytotoxicity
9%
Phosphorylation
9%
Tumor Growth
9%
Cell Proliferation
9%
Inducer
9%
Overexpression
9%
Antitumor Activity
9%
In Vitro Assay
9%
Treatment Outcome
9%
Novel Therapeutics
9%
Functional Studies
9%
Malignancy
9%
Molecular Docking Studies
9%
Anticancer Potential
9%
Survival Rate
9%
Increased Incidence
9%
Anticancer Properties
9%
Strategies to Overcome
9%
Multiple Cancers
9%
Xenograft Model
9%
Autophagy Inhibition
9%
Current Treatment
9%
Kinase Inhibitor
9%
Bioactive Flavonoid
9%
Highly Aggressive
9%
Gemcitabine
9%
Executor
9%
Gasdermin E (GSDME)
9%
Gasdermin D (GSDMD)
9%
Treatment Agent
9%
Glycyrrhiza Species
9%
Inflammatory Cell Death
9%
Tumor Histology
9%
Clinical Exploration
9%
Pharmacology, Toxicology and Pharmaceutical Science
Pancreas Adenocarcinoma
100%
Licochalcone A
100%
Pyroptosis
100%
Elongation Factor 2 Kinase
100%
Survival Rate
9%
Flavonoid
9%
Cytotoxicity
9%
Antiinfective Agent
9%
Tumor Growth
9%
Neoplasm
9%
Antitumor Activity
9%
Phosphotransferase Inhibitor
9%
Cyclic AMP Dependent Protein Kinase
9%
Multiple Cancer
9%
Gemcitabine
9%
Glycyrrhiza
9%
Elongation Factor 2
9%